Provided by Tiger Fintech (Singapore) Pte. Ltd.

Humacyte, Inc.

1.19
-0.0200-1.65%
Post-market: 1.210.0199+1.67%19:55 EDT
Volume:2.02M
Turnover:2.44M
Market Cap:184.59M
PE:-0.95
High:1.25
Open:1.24
Low:1.18
Close:1.21
Loading ...
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Correspondence

Form CORRESP - Correspondence
Jul 31, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]